Your browser is no longer supported. Please, upgrade your browser.
Settings
NVCR NovoCure Limited daily Stock Chart
NVCR [NASD]
NovoCure Limited
Index- P/E- EPS (ttm)-0.29 Insider Own1.40% Shs Outstand101.17M Perf Week-8.55%
Market Cap7.88B Forward P/E207.02 EPS next Y0.38 Insider Trans-56.42% Shs Float81.79M Perf Month-3.68%
Income-27.10M PEG- EPS next Q0.00 Inst Own74.60% Short Float4.46% Perf Quarter-1.83%
Sales321.80M P/S24.47 EPS this Y36.50% Inst Trans0.53% Short Ratio5.08 Perf Half Y41.32%
Book/sh1.93 P/B40.33 EPS next Y416.70% ROA-7.00% Target Price86.57 Perf Year115.38%
Cash/sh3.09 P/C25.19 EPS next 5Y- ROE-18.50% 52W Range28.83 - 98.70 Perf YTD132.50%
Dividend- P/FCF278.27 EPS past 5Y5.90% ROI-19.60% 52W High-21.13% Beta2.44
Dividend %- Quick Ratio4.80 Sales past 5Y88.70% Gross Margin73.00% 52W Low169.99% ATR3.34
Employees598 Current Ratio5.10 Sales Q/Q42.10% Oper. Margin-3.00% RSI (14)35.30 Volatility4.05% 3.84%
OptionableYes Debt/Eq0.78 EPS Q/Q114.30% Profit Margin-8.40% Rel Volume1.66 Prev Close78.90
ShortableYes LT Debt/Eq0.78 EarningsOct 31 BMO Payout- Avg Volume717.94K Price77.84
Recom2.30 SMA20-10.62% SMA50-2.55% SMA20015.51% Volume1,188,874 Change-1.34%
Jul-29-19Upgrade SunTrust Hold → Buy
Jul-26-19Downgrade Wedbush Outperform → Neutral $57 → $80
Jul-26-19Downgrade JP Morgan Overweight → Neutral $61 → $79
Mar-20-19Initiated SunTrust Hold
Nov-02-18Downgrade Wells Fargo Outperform → Market Perform
Jul-16-18Initiated Evercore ISI Outperform $46
Apr-18-18Reiterated Mizuho Buy $28 → $32
Feb-23-18Reiterated Mizuho Buy $25 → $28
May-24-17Upgrade Wells Fargo Market Perform → Outperform
Jul-29-16Reiterated Wedbush Outperform $30 → $20
Jan-19-16Initiated Barclays Underweight $16
Dec-02-15Initiated Deutsche Bank Hold $28
Oct-27-15Initiated Wedbush Outperform
Oct-27-15Initiated JP Morgan Overweight
Oct-27-15Initiated JMP Securities Mkt Outperform $43
Dec-08-19 07:11PM  Heres What Hedge Funds Think About NovoCure Limited (NVCR) Insider Monkey
Dec-04-19 04:05PM  SI-BONE Names Jeryl (Jeri) Hilleman to Board of Directors GlobeNewswire
09:55AM  Raise Stops on NovoCure TheStreet.com
Dec-02-19 07:30AM  Novocure and the AACR Announce 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program Business Wire
05:00AM  Novocure- A New Way to Target Tumors MoneyShow
Nov-26-19 07:30AM  Novocure to Participate in the Evercore ISI 2019 HealthCONx Conference TEST Business Wire Releases
07:30AM  Novocure to Participate in the Evercore ISI 2019 HealthCONx Conference Business Wire
Nov-20-19 07:30AM  Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology Business Wire
Nov-04-19 09:35AM  Edited Transcript of NVCR earnings conference call or presentation 31-Oct-19 12:00pm GMT Thomson Reuters StreetEvents
Nov-01-19 11:10AM  NovoCure Looks Ready to Resume Its Strong Uptrend After a Correction TheStreet.com +5.19%
Oct-31-19 07:35AM  NovoCure (NVCR) Q3 Earnings and Revenues Beat Estimates Zacks
06:00AM  Novocure Reports Third Quarter 2019 Financial Results and Provides Company Update Business Wire
06:00AM  Novocure Ltd. to Host Earnings Call ACCESSWIRE
Oct-27-19 10:08AM  3 Monster Growth Stocks to Hold Through 2020 TipRanks
Oct-24-19 10:32AM  Will NovoCure (NVCR) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-18-19 07:35AM  Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar? Zacks
Oct-16-19 10:31AM  Results from STELLAR Trial of Tumor Treating Fields with Chemotherapy in Malignant Pleural Mesothelioma Published in The Lancet Oncology Business Wire
Oct-14-19 06:13PM  Did Hedge Funds Drop The Ball On NovoCure Limited (NVCR) ? Insider Monkey
01:31PM  How Many NovoCure Limited (NASDAQ:NVCR) Shares Have Insiders Sold, In The Last Year? Simply Wall St.
Oct-01-19 07:30AM  Novocure to Report Third Quarter 2019 Financial Results Business Wire
Sep-13-19 06:59PM  Novocure (NVCR) CFO Wilhelmus Cm Groenhuysen Sold $3.9 million of Shares GuruFocus.com
Sep-11-19 07:15PM  Novocure (NVCR) CFO Wilhelmus Cm Groenhuysen Sold $3.9 million of Shares GuruFocus.com
Sep-09-19 11:34AM  10 Stocks to Sell in Market-Cursed September InvestorPlace -8.23%
09:25AM  Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting Business Wire
Sep-04-19 09:44AM  Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar? Zacks
Aug-30-19 06:54PM  Small-Cap Stocks Show Stealth Buying Pattern Investopedia
Aug-29-19 08:50AM  Is NovoCure (NASDAQ:NVCR) Weighed On By Its Debt Load? Simply Wall St.
Aug-27-19 11:37AM  Jim Cramer Gives His Opinion On Novocure, Morgan Stanley And More Benzinga
Aug-14-19 05:38AM  Novocure's Charts Are as Bullish As They Get, So Here's My Strategy TheStreet.com
Aug-13-19 07:01AM  Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar? Zacks
Aug-12-19 07:30AM  China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China GlobeNewswire
07:30AM  China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China Business Wire
Aug-07-19 11:17AM  Jim Cramer Weighs In On Funko, Citigroup And More Benzinga
10:26AM  NovoCure Looks Due for a Technical Correction TheStreet.com
Aug-06-19 09:01AM  Novocure to Participate in Three Upcoming Investor Conferences Business Wire
Aug-04-19 07:00PM  Why NovoCure Stock Soared 32% in July Motley Fool
Jul-31-19 01:13AM  NovoCure Limited (NVCR) Q2 2019 Earnings Call Transcript Motley Fool
Jul-30-19 12:32AM  Edited Transcript of NVCR earnings conference call or presentation 25-Jul-19 12:00pm GMT Thomson Reuters StreetEvents
Jul-26-19 08:57AM  NovoCure Limited (NVCR) Shares March Higher, Can It Continue? Zacks
Jul-25-19 02:52PM  Why NovoCure Stock Is Surging Today Motley Fool +8.58%
01:59PM  NovoCure Nears Profitability as Revenue Continues to Soar Motley Fool
07:30AM  NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates Zacks
06:00AM  Novocure Reports Second Quarter 2019 Financial Results and Provides Company Update Business Wire
Jul-24-19 07:54AM  Are Investors Undervaluing NovoCure Limited (NASDAQ:NVCR) By 43%? Simply Wall St.
Jul-22-19 10:11AM  Can NovoCure's (NVCR) Steady Optune Business Aid Q2 Earnings? Zacks
07:30AM  Novocure Announces 10 Oral Presentations and a Special Session on Tumor Treating Fields at the 41st International Engineering in Medicine and Biology Conference Business Wire
Jul-18-19 07:11PM  CMS Establishes 2019 Monthly Fee Schedule Amount for Optune® Business Wire
10:33AM  NovoCure (NVCR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Zacks
06:57AM  Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma Business Wire
Jul-05-19 03:32PM  Novocure Stock Gave Quick Swing Trading Profit Investor's Business Daily
Jul-03-19 08:21AM  Why NovoCure Stock Jumped 19% in June Motley Fool
Jul-02-19 07:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $11.7 million of Shares GuruFocus.com
07:30AM  Novocure to Report Second Quarter 2019 Financial Results Business Wire
Jun-29-19 06:00AM  3 Cancer-Treatment Stocks to Buy Motley Fool
Jun-28-19 09:00AM  NovoCure (NVCR) Jumps: Stock Rises 7.1% Zacks
Jun-26-19 07:30AM  German Institute for Quality and Efficiency in Healthcare Publishes Rapid Report Noting Optunes Survival Benefit for Patients with Newly Diagnosed Glioblastoma Business Wire
Jun-24-19 08:22AM  What does NovoCure Limited's (NASDAQ:NVCR) Balance Sheet Tell Us About Its Future? Simply Wall St.
Jun-19-19 07:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $11.3 million of Shares GuruFocus.com
Jun-18-19 10:44AM  Novocure Could Climb Even Further; Here's Where to Buy TheStreet.com
Jun-14-19 09:08AM  Hedge Funds Have Never Been This Bullish On NovoCure Limited (NVCR) Insider Monkey
Jun-12-19 04:39PM  Why NovoCure's Regulatory News Is a Huge Win for Investors Motley Fool
03:13PM  Is NovoCure Limited's (NASDAQ:NVCR) CEO Overpaid Relative To Its Peers? Simply Wall St.
Jun-07-19 08:34AM  You Need This IPO On Your Radar Motley Fool
Jun-06-19 07:50AM  Why NovoCure Stock Jumped 20.5% in May Motley Fool
Jun-03-19 07:45AM  3 Fast-Growing Healthcare Stocks to Buy If the Market Crashes Motley Fool
May-24-19 07:44AM  The Daily Biotech Pulse: FDA Nod For Novocure, Dynavax Restructures, Therapix Receives Nasdaq Notice Benzinga +7.30%
07:30AM  Novocure to Participate in the Jefferies 2019 Global Healthcare Conference Business Wire
May-23-19 04:05PM  FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma Business Wire
May-13-19 03:00AM  Insulet and Novocure Are Going Gangbusters Motley Fool
May-10-19 06:30AM  Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma Business Wire
May-08-19 04:10PM  Edited Transcript of NVCR earnings conference call or presentation 2-May-19 12:00pm GMT Thomson Reuters StreetEvents
May-07-19 10:38AM  5 Key Takeaways From NovoCure's Big First-Quarter Motley Fool
May-03-19 12:48AM  NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript Motley Fool +9.62%
May-02-19 12:02PM  NovoCure Limited (NVCR) Q1 2019 Earnings Call Transcript Motley Fool
08:16AM  The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data Benzinga
07:30AM  NovoCure (NVCR) Reports Q1 Loss, Misses Revenue Estimates Zacks
07:18AM  NovoCure: 1Q Earnings Snapshot Associated Press
06:00AM  Novocure Reports First Quarter 2019 Financial Results and Provides Company Update Business Wire
Apr-30-19 02:20PM  The NovoCure (NASDAQ:NVCR) Share Price Is Up 275% And Shareholders Are Boasting About It Simply Wall St.
07:30AM  Novocure Announces the International Journal of Radiation Oncology, Biology, Physics Publishes Data Demonstrating Higher Doses of Tumor Treating Fields Improved Survival of Newly Diagnosed Glioblastoma Patients Business Wire
07:01AM  Jim Cramer Weighs In On Canopy Growth, Levi, Twilio And More Benzinga
Apr-26-19 10:17AM  Did Hedge Funds Drop The Ball On NovoCure Limited (NVCR) ? Insider Monkey
Apr-25-19 10:33AM  NovoCure (NVCR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-15-19 07:30AM  Novocure Publishes 2018 Annual Report Featuring Companys Vision, Mission and Values Business Wire
Apr-10-19 02:10PM  What You Should Know About NovoCure Limited's (NASDAQ:NVCR) Financial Strength Simply Wall St.
Apr-06-19 03:45PM  Why Novocure Stock Fell More Than 10% in March Motley Fool
Apr-03-19 07:30AM  Inaugural AACR-Novocure Tumor Treating Fields Research Grant Recipients Announced at AACR Annual Meeting 2019 Business Wire
Apr-02-19 07:30AM  Novocure to Report First Quarter 2019 Financial Results Business Wire
Mar-29-19 07:50AM  Investor Expectations to Drive Momentum within Apple Hospitality REIT, Superior Energy Services, US Foods Holding, NovoCure, FTS International, and Envestnet Discovering Underlying Factors of Influence GlobeNewswire
Mar-22-19 07:30AM  Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer Business Wire -5.92%
Mar-21-19 07:30AM  Novocure Announces 48 Presentations and a Symposium Session on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2019 Business Wire
06:52AM  Novocure Chief Science Officer Eilon Kirson to retire after 7 years in the role MarketWatch
06:30AM  Novocures Chief Science Officer Retires after 17 Years of Service Business Wire
Mar-18-19 07:30AM  Novocure to Participate in Oppenheimers 29th Annual Healthcare Conference Business Wire
Mar-12-19 09:37AM  Does NovoCure Limiteds (NASDAQ:NVCR) Past Performance Indicate A Weaker Future? Simply Wall St.
Mar-08-19 08:45AM  Options Traders Expect Huge Moves in NovoCure (NVCR) Stock Zacks
Mar-04-19 11:58PM  Edited Transcript of NVCR earnings conference call or presentation 28-Feb-19 1:00pm GMT Thomson Reuters StreetEvents -5.83%
06:15PM  Novocure Ltd (NVCR) CEO Asaf Danziger Sold $5.6 million of Shares GuruFocus.com
Feb-28-19 03:21PM  NovoCure (NVCR) Q4 2018 Earnings Conference Call Transcript Motley Fool
06:00AM  Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update Business Wire
Markets a wearable electric field device for treating glioblastoma brain cancer.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PHILLIPS CHARLES G IIIDirectorDec 02Sale88.116,145541,4483,359Dec 04 04:23 PM
LEUNG GABRIELDirectorNov 25Option Exercise7.0320,000140,60089,504Nov 26 04:23 PM
Danziger AsafChief Executive OfficerNov 25Option Exercise22.00103,0002,266,000237,601Nov 26 04:28 PM
LEUNG GABRIELDirectorNov 25Sale95.0020,0001,900,00069,504Nov 26 04:23 PM
Danziger AsafChief Executive OfficerNov 25Sale95.00103,0009,785,000134,601Nov 26 04:28 PM
DOYLE WILLIAM FExecutive ChairmanNov 25Sale96.0416,2231,558,057643,242Nov 26 04:29 PM
LEUNG GABRIELDirectorNov 20Option Exercise7.0320,000140,60089,504Nov 22 04:27 PM
DOYLE WILLIAM FExecutive ChairmanNov 20Sale90.36150,00013,553,723659,465Nov 22 04:22 PM
LEUNG GABRIELDirectorNov 20Sale90.0020,0001,800,00069,504Nov 22 04:27 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 18Option Exercise3.445,83220,06293,011Nov 19 04:22 PM
LEUNG GABRIELDirectorNov 18Option Exercise7.0310,00070,30079,504Nov 19 04:24 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 18Sale85.995,832501,47087,179Nov 19 04:22 PM
LEUNG GABRIELDirectorNov 18Sale85.0010,000850,00069,504Nov 19 04:24 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 15Option Exercise3.4420,00068,800107,179Nov 19 04:22 PM
LEUNG GABRIELDirectorNov 15Option Exercise5.3310,00053,27374,761Nov 19 04:24 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 15Sale83.2520,0001,665,09387,179Nov 19 04:22 PM
LEUNG GABRIELDirectorNov 15Sale83.2410,000832,35469,504Nov 19 04:24 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 14Option Exercise3.7527,576103,503107,179Nov 15 04:25 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 14Sale81.8727,5762,257,68987,179Nov 15 04:25 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 13Option Exercise4.3440,000173,500107,179Nov 15 04:25 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 13Sale80.8740,0003,234,61787,179Nov 15 04:25 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 12Option Exercise4.3440,000173,500107,179Nov 13 04:30 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 12Sale80.1740,0003,206,81087,179Nov 13 04:30 PM
DOYLE WILLIAM FExecutive ChairmanNov 12Sale81.6813,2181,079,616809,465Nov 13 04:31 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 11Option Exercise4.238,60036,40591,979Nov 13 04:30 PM
LEUNG GABRIELDirectorNov 11Option Exercise3.445,00017,20074,504Nov 13 04:33 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerNov 11Sale80.138,600689,11587,179Nov 13 04:30 PM
DOYLE WILLIAM FExecutive ChairmanNov 11Sale80.1129,7822,385,776822,683Nov 13 04:31 PM
LEUNG GABRIELDirectorNov 11Sale79.575,000397,85069,504Nov 13 04:33 PM
Ambrogi Michael J.Chief Operating OfficerNov 04Option Exercise20.6980,8191,672,467222,631Nov 06 04:27 PM
Ambrogi Michael J.Chief Operating OfficerNov 04Sale79.0080,8196,384,701185,674Nov 06 04:27 PM
Shah PriteshChief Commercial OfficerOct 24Option Exercise7.484,58034,25867,721Oct 28 04:28 PM
LEUNG GABRIELDirectorOct 10Option Exercise3.445,00017,20074,504Oct 15 04:12 PM
LEUNG GABRIELDirectorOct 10Sale72.285,000361,40069,504Oct 15 04:12 PM
GROENHUYSEN WILHELMUS CMCFOSep 24Option Exercise4.327,99234,53291,210Sep 26 07:52 PM
GROENHUYSEN WILHELMUS CMCFOSep 24Sale80.637,992644,39887,179Sep 26 07:52 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 16Option Exercise3.4425,00086,000112,179Sep 17 04:37 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 16Sale78.9325,0001,973,33487,179Sep 17 04:37 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 13Option Exercise3.4425,00086,000112,179Sep 17 04:37 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 13Sale79.8225,0001,995,54887,179Sep 17 04:37 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 12Option Exercise3.4425,00086,000112,179Sep 13 04:16 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 12Sale79.5725,0001,989,27887,179Sep 13 04:16 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 11Option Exercise3.4425,00086,000112,179Sep 13 04:16 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 11Sale77.9825,0001,949,56487,179Sep 13 04:16 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 10Option Exercise3.4425,00086,000112,179Sep 11 04:11 PM
LEUNG GABRIELDirectorSep 10Option Exercise3.445,00017,20074,504Sep 12 04:04 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 10Sale75.5525,0001,888,63587,179Sep 11 04:11 PM
LEUNG GABRIELDirectorSep 10Sale76.635,000383,15069,504Sep 12 04:04 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 09Option Exercise3.4425,00086,000112,179Sep 11 04:11 PM
GROENHUYSEN WILHELMUS CMChief Financial OfficerSep 09Sale80.8325,0002,020,74687,179Sep 11 04:11 PM
Longsworth Todd ChristopherGeneral CounselSep 03Option Exercise9.64158,4401,528,047113,420Sep 05 04:09 PM
Longsworth Todd ChristopherGeneral CounselSep 03Sale87.87158,44013,922,58953,900Sep 05 04:09 PM
PHILLIPS CHARLES G IIIDirectorAug 30Option Exercise6.7222,000147,84031,504Sep 03 04:22 PM
PHILLIPS CHARLES G IIIDirectorAug 30Sale91.1422,0002,005,1189,504Sep 03 04:22 PM
VERNON W ANTHONYDirectorAug 29Sale91.03100,0009,103,100158,589Sep 03 04:20 PM
Danziger AsafChief Executive OfficerAug 29Sale91.13124,18111,316,198134,601Sep 03 04:24 PM
LEUNG GABRIELDirectorAug 12Option Exercise3.445,00017,20074,504Aug 14 04:18 PM
LEUNG GABRIELDirectorAug 12Sale86.455,000432,25069,504Aug 14 04:18 PM
Shah PriteshChief Commercial OfficerAug 02Sale85.231,813154,52276,976Aug 06 04:43 PM
Shah PriteshChief Commercial OfficerAug 01Sale83.201,905158,50278,789Aug 02 04:13 PM
Shah PriteshChief Commercial OfficerJul 31Option Exercise54.758,833483,61982,091Aug 02 04:13 PM
Shah PriteshChief Commercial OfficerJul 31Sale82.925,115424,13676,976Aug 02 04:13 PM
Shah PriteshChief Commercial OfficerJul 26Option Exercise19.2512,500240,62589,476Jul 30 03:57 PM
Shah PriteshChief Commercial OfficerJul 26Sale77.9412,500974,20876,976Jul 30 03:57 PM
Shah PriteshChief Commercial OfficerJul 18Option Exercise27.607,500207,00084,476Jul 22 10:47 AM
Shah PriteshChief Commercial OfficerJul 18Sale70.007,500525,00076,976Jul 22 10:47 AM
LEUNG GABRIELDirectorJul 10Option Exercise3.445,00017,20074,504Jul 12 04:04 PM
LEUNG GABRIELDirectorJul 10Sale64.835,000324,15569,504Jul 12 04:04 PM
Danziger AsafChief Executive OfficerJun 28Option Exercise7.15187,5001,340,625445,811Jul 02 04:12 PM
Danziger AsafChief Executive OfficerJun 28Sale62.15187,50011,653,125258,311Jul 02 04:12 PM
Shah PriteshChief Commercial OfficerJun 27Sale60.3011,175673,85365,037Jun 28 06:55 PM
Ambrogi Michael J.Chief Operating OfficerJun 19Option Exercise22.00110,8682,439,096296,542Jun 21 04:01 PM
Danziger AsafChief Executive OfficerJun 19Option Exercise11.4625,000286,500283,311Jun 21 04:03 PM
LEUNG GABRIELDirectorJun 19Option Exercise3.4425,00086,00094,504Jun 21 04:05 PM
Shah PriteshChief Commercial OfficerJun 19Option Exercise11.8512,500148,12588,712Jun 21 04:06 PM
Ambrogi Michael J.Chief Operating OfficerJun 19Sale60.00110,8686,652,080185,674Jun 21 04:01 PM
Danziger AsafChief Executive OfficerJun 19Sale61.4625,0001,536,500258,311Jun 21 04:03 PM
LEUNG GABRIELDirectorJun 19Sale60.0225,0001,500,50069,504Jun 21 04:05 PM
Shah PriteshChief Commercial OfficerJun 19Sale60.0012,500750,00076,212Jun 21 04:06 PM
Danziger AsafChief Executive OfficerJun 18Option Exercise14.37190,3382,735,157448,649Jun 19 04:16 PM
Danziger AsafChief Executive OfficerJun 18Sale59.37190,33811,300,367258,311Jun 19 04:16 PM
Danziger AsafChief Executive OfficerJun 12Option Exercise14.3730,436437,365288,747Jun 13 04:16 PM
Danziger AsafChief Executive OfficerJun 12Sale55.3930,4361,685,965258,311Jun 13 04:16 PM
Danziger AsafChief Executive OfficerJun 11Option Exercise14.3716,835241,919275,146Jun 13 04:16 PM
Danziger AsafChief Executive OfficerJun 11Sale54.7516,835921,651258,311Jun 13 04:16 PM
LEUNG GABRIELDirectorJun 10Option Exercise3.445,00017,20074,504Jun 12 04:12 PM
LEUNG GABRIELDirectorJun 10Sale55.055,000275,26669,504Jun 12 04:12 PM
Shah PriteshChief Commercial OfficerJun 10Sale55.051,13062,21276,212Jun 12 04:13 PM
Ambrogi Michael J.Chief Operating OfficerJun 06Option Exercise7.155,99942,893191,673Jun 10 04:13 PM
Ambrogi Michael J.Chief Operating OfficerJun 06Sale54.795,999328,661185,674Jun 10 04:13 PM
Ambrogi Michael J.Chief Operating OfficerJun 05Option Exercise7.1517,500125,125203,174Jun 06 04:10 PM
Ambrogi Michael J.Chief Operating OfficerJun 05Sale54.1417,500947,485185,674Jun 06 04:10 PM
Ambrogi Michael J.Chief Operating OfficerJun 04Option Exercise7.1517,500125,125203,174Jun 05 04:33 PM
Ambrogi Michael J.Chief Operating OfficerJun 04Sale53.1217,500929,613185,674Jun 05 04:33 PM
Ambrogi Michael J.Chief Operating OfficerJun 03Option Exercise7.1517,500125,125203,174Jun 05 04:33 PM
Ambrogi Michael J.Chief Operating OfficerJun 03Sale52.1217,500912,128185,674Jun 05 04:33 PM
DOYLE WILLIAM FExecutive ChairmanMay 30Sale53.0748,1002,552,523846,463Jun 03 04:08 PM
PHILLIPS CHARLES G IIIDirectorMay 29Option Exercise9.1695,100871,16559,504May 31 04:11 PM
PHILLIPS CHARLES G IIIDirectorMay 29Sale52.1795,1004,961,1989,504May 31 04:11 PM
DOYLE WILLIAM FExecutive ChairmanMay 29Sale53.101,900100,881894,563May 31 04:12 PM